The 2'-5' oligoadenylate/RNase L/RNase L inhibitor pathway regulates both MyoD mRNA stability and muscle cell differentiation

Molecular and Cellular Biology

Volumn 20, Issue 14, 2000, Pages 4959-4969

  Bisbal, C ^a,b   Silhol, M ^a   Laubenthal, H ^a   Kaluza, T ^a   Carnac, G ^b   Milligan, L ^a   Le Roy, F ^a   Salehzada, T ^a,b  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^b INSTITUTE OF HUMAN GENETICS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2' 5' OLIGOADENYLATE RIBONUCLEASE L; 2' 5' OLIGOADENYLATE RIBONUCLEASE L INHIBITOR; RIBONUCLEASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUSION; ENZYME ACTIVITY; ENZYME DEGRADATION; GENETIC TRANSFECTION; MESSENGER RNA SYNTHESIS; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; PROTEIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS REGULATION; RNA DEGRADATION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELL DIFFERENTIATION; CELLS, CULTURED; CHAPERONINS; DNA, ANTISENSE; ENDORIBONUCLEASES; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HALF-LIFE; ISOPROPYL THIOGALACTOSIDE; MICE; MUSCLE, SKELETAL; MYOD PROTEIN; MYOGENIN; PROTEINS; RNA STABILITY; RNA, MESSENGER; TRANSFECTION;

EID: 0033919776     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.14.4959-4969.2000     Document Type: Article

References (53)

1. Andre, P., S. Braun, A. Passaquin, G. Coupin, J. Bartholeyns, J. Warter, and P. Poindron. 1988. Rat interferon enhances the expression of acetylcholine receptors in rat myotubes in culture. J. Neurosci. Res. 19:297-302.
2. Bayard, B., C. Bisbal, M. Silhol, J. Cnockaert, G. Huez, and B. Lebleu. 1984. Increased stability and antiviral activity of 2′-O-phosphoglyceryl derivatives of (2′-5′)oligo(adenylate). Eur. J. Biochem. 142:291-298.
3. Benoit De Coignac, A., C. Bisbal, B. Lebleu, and T. Salehzada. 1998. cDNA cloning and expression analysis of the murine ribonuclease L inhibitor. Gene 209:149-156.
4. Birnbaum, M., B. Trink, A. Shainberg, and S. Salzberg. 1990. Activation of the interferon system during myogenesis in vitro. Differentiation 45:138-145.
5. Bisbal, C., C. Martinand, M. Silhol, B. Lebleu, and T. Salehzada. 1995. Cloning and characterization of an RNase L inhibitor. A new component of the interferon-regulated 2-5A pathway. J. Biol. Chem. 270:13308-13317.
6. Bisbal, C., T. Salehzada, B. Lebleu, and B. Bayard. 1989. Characterization of two murine (2′-5′)(A)n-dependent endonucleases of different molecular mass. Eur. J. Biochem. 179:595-602.
7. Bonnieu, A., J. Rech, P. Jeanteur, and P. Fort. 1989. Requirements for c-fos mRNA downregulation in growth stimulated murine cells. Oncogene 4:881-888.
8. Braun, T., E. Bober, D. G. Buschhausen, S. Kohlz, K. H. Grzeschik, H. H. Arnold, and S. Kotz. 1989. Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products. EMBO J. 8:3617-3625. (Erratum, 8:4358.)
9. Datta, B., W. Min, S. Burma, and P. Lengyel. 1998. Increase in p202 expression during skeletal muscle differentiation: inhibition of MyoD protein expression and activity by p202. Mol. Cell. Biol. 18:1074-1083.
10. Dias, P., D. M. Parham, D. N. Shapiro, S. J. Tapscott, and P. J. Houghton. 1992. Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility. Cancer Res. 52:6431-6439.
11. Dong, B., and R. H. Silverman. 1995. 2-5A-dependent RNase molecules dimerize during activation by 2-5A. J. Biol. Chem. 270:4133-4137.
12. Dong, B., L. Xu, A. Zhou, B. A. Hassel, X. Lee, P. F. Torrence, and R. H. Silverman. 1994. Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase. J. Biol. Chem. 269:14153-14158.
13. Fisher, P. B., A. F. Miranda, L. E. Babiss, S. Pestka, and I. B. Weinstein. 1983. Opposing effects of Interferon produced in bacteria and of tumor promoters on myogenesis in human myoblast cultures. Proc. Natl. Acad. Sci. USA 80:2961-2965.
14. Floyd-Smith, G., E. Slattery, and P. Lengyel. 1981. Interferon action: RNA cleavage pattern of a (2′-5′)oligoadenylate-dependent endonuclease. Science 212:1030-1032.
15. Greenberg, M. E., and E. B. Ziff. 1984. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311:433-438.
16. Gribaudo, G., D. Lembo, G. Cavallo, S. Landolfo, and P. Lengyel. 1991. Interferon action: binding of viral RNA to the 40-kilodalton 2′-5′-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. J. Virol. 65:1748-1757.
17. Hollenberg, S. M., P. F. Cheng, and H. Weintraub. 1993. Use of a conditional MyoD transcription factor in studies of MyoD trans-activation and muscle determination. Proc. Natl. Acad. Sci. USA 90:8028-8032.
18. Kariko, K., S. W. Li, R J. Sobol, R. J. Suhadolnik, R. Charubala, and W. Pfleiderer. 1987. Phosphorothioate analogues of 2′,5′-oligoadenylate: activation of 2′,5′-oligoadenylate-dependent endoribonuclease by 2′,5′-phosphorothioate cores and 5′-monophosphates. Biochemistry 26:7136-7142.
19. Kariko, K., and J. Ludwig. 1985. n-Decyl-NHpppA2′p5′A2′p5′A: a phosphatase-resistant, active pppA2′p5′A2′p5′A analog. Biochem. Biophys. Res. Commun. 128:695-698.
20. Kariko, K., R. J. Sobol, L. Suhadolnik, S. W. Li, N. L. Reichenbach, R. J. Suhadolnik, R. Charubala, and W. Pfleiderer. 1987. Phosphorothioate analogues of 2′,5′-oligoadenylate. Enzymatically synthesized 2′,5′-phosphorothioate dimer and trimer: unequivocal structural assignment and activation of 2′,5′-oligoadenylate-dependent endoribonuclease. Biochemistry 26:7127-7135.
21. Kerr, I. M., and R. E. Brown. 1978. pppA2′p5′A2′p5′A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc. Natl. Acad. Sci. USA 75:256-260.
22. Knight, M., P. J. Cayley, R. H. Silverman, D. H. Wreschner, C. S. Gilbert, R. E. Brown, and I. M. Kerr. 1980. Radioimmune, radiobinding and HPLC analysis of 2-5A and related oligonucleotides from intact cells. Nature 288: 189-192.
23. Kronfeld, K. Y., S. Vilchik, T. Hyman, F. Leibkowicz, and S. Salzberg. 1999. Involvement of PKR in the regulation of myogenesis. Cell Growth Differ. 10:201-212.
24. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
25. Li, X. L., J. A. Blackford, and B. A. Hassel. 1998. RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection. J. Virol. 72:2752-2759.
26. Lough, J., S. Keay, J, L. Sabran, and S. E. Grossberg. 1982. Inhibition of chicken myogenesis in vitro by partially purified interferon. Biochem. Biophys. Res. Commun. 109:92-99.
27. Martinand, C., C. Montavon, T. Salehzada, M. Silhol, B. Lebleu, and C. Bisbal. 1999. RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and downregulates the 2-5A/RNase L pathway in human T cells. J. Virol. 73:290-296.
28. Martinand, C., T. Salehzada, M. Silhol, B. Lebleu, and C. Bisbal. 1998. RNase L inhibitor (RLI) antisense constructions block partially the down-regulation of the 2-5A/RNase L pathway in encephalomyocarditis virus (EMCV)-infected cells. Eur. J. Biochem. 254:238-247.
29. Montarras, D., F. Aurade, T. Johnson, J. Ilan, F. Gros, and C. Pinset. 1996. Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutual positive control between insulin-like growth factor II and MyoD, operating as early as at the myoblast stage. J. Cell Sci. 109:551-560.
30. Montarras, D., J. Chelly, E. Bober, H. Arnold, M. O. Ott, F. Gros, and C. Pinset. 1991. Developmental patterns in the expression of Myf5, MyoD, myogenin, and MRF4 during myogenesis. New Biol. 3:592-600.
31. Multhauf, C., and J. Lough. 1986. Interferon-mediated inhibition of differentiation in a murine myoblast cell line. J. Cell Physiol. 126:211-215.
32. Olson, E. N. 1990. MyoD family: a paradigm for development? Genes Dev. 4:1454-1461.
33. Pinset, C., D. Montarras, J. Chenevert, A. Minty, P. Barton, C. Laurent, and F. Gros. 1988. Control of myogenesis in the mouse myogenic C2 cell line by medium composition and by insulin: characterization of permissive and inducible C2 myoblasts. Differentiation 38:28-34.
34. Romeo, G., E. Affarbis, A. Battistini, and G. Rossi. 1992. Cell and animal effects of IFNs: natural occurrence and differentiation effects and mechanisms, p. 271-287. In S. Baron, D. H. Coppenhaver, F. Dianzani, R. Fleischmann, T. K. Hughes, G. R. Klimpel, D. W. Niesel, G. J. Stanton, and S. K. Tyring (ed.), Interferon: principles and medical applications. The University of Texas Medical Branch at Galveston Department of Microbiology, Galveston, Tex.
35. Rysiecki, G., D. R. Gewert, and B. R. Williams. 1989. Constitutive expression of a 2′,5′-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. J. Interferon Res. 9:649-657.
36. Salzberg, S., T. Hyman, H. Turm, Y. Kinar, Y. Schwartz, U. Nir, F. Lejbkowicz, and E. Huberman. 1997. Ectopic expression of 2-5A synthetase in myeloid cells induces growth arrest and facilitates the appearance of a myeloid differentiation marker. Cancer Res. 57:2732-2740.
37. Salzberg, S., F. Lanciano, and D. Hacohen. 1990. Reversibility of the anti-proliferative effect of interferon. Nat. Immun. Cell Growth Regul. 9:191-202.
38. Salzberg, S., M. Mandelboim, M. Zalcberg, A. Shainberg, Mandelbaum, M. 1995. Interruption of myogenesis by transforming growth factor beta 1 or EGTA inhibits expression and activity of the myogenic-associated (2′-5′) oligoadenylate synthetase and PKR. Exp. Cell Res. 219:223-232. (Erratum, 220:509.)
39. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
40. Sassoon, D. A. 1993. Myogenic regulatory factors: dissecting their role and regulation during vertebrate embryogenesis. Dev. Biol. 156:11-23.
41. Sen, G. C., and P. Lengyel. 1992. The interferon system: a bird's eye view of its biochemistry. J. Biol. Chem. 267:5017-5020.
42. Silverman, R. H., J. J. Skehel, T. C. James, D. H. Wreschner, and I. M. Kerr. 1983. rRNA cleavage as an index of ppp(A2′p)nA activity in interferon-treated encephalomyocarditis virus-infected cells. J. Virol. 46:1051-1055.
43. Thayer, M. J., S. J. Tapscott, R. L. Davis, W. E. Wright, A. B. Lassar, and H. Weintraub. 1989. Positive autoregulation of the myogenic determination gene MyoD1. Cell 58:241-248.
44. Tomita, Y., and S. Hasegawa. 1984. Multiple effects of interferon on myogenesis in chicken myoblast cultures. Biochim. Biophys. Acta 804:370-376.
45. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
46. Vincent, S., L. Marty, and P. Fort. 1993. S26 ribosomal protein RNA: an invariant control for gene regulation experiments in eucaryotic cells and tissues. Nucleic Acids Res. 21:1498.
47. Weintraub, H. 1993. The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell 75:1241-1244.
48. Whitaker, J. R., and P. E. Granum. 1980. An absolute method for protein determination based on difference in absorbance at 235 and 280 nm. Anal. Biochem. 109:156-159.
49. Wreschner, D. H., T. C. James, R. H. Silverman, and I. M. Kerr. 1981. Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2′p)nA) in interferon-treated cells. Nucleic Acids Res. 9:1571-1581.
50. Wreschner, D. H., R. H. Silverman, T. C. James, C. S. Gilbert, and I. M. Kerr. 1982. Affinity labelling and characterization of the ppp(A2′p)nA-dependent endoribonuclease from different mammalian sources. Eur. J. Biochem. 124:261-268.
51. Yaffe, A., Y. Schwarz, D. Hacohen, Y. Kinar, U. Nir, and S. Salzberg. 1996. Inhibition of 2-5A synthetase expression by antisense RNA interferes with interferon-mediated antiviral and antiproliferative effects and induces anchorage-independent cell growth. Cell Growth Differ. 7:969-978.
52. Yaffe, D., and O. Saxel. 1977. Serial passaging and differentiation of myogenic ceils isolated from dystrophic mouse muscle. Nature 270:725-727.
53. Zhou, A., B. A. Hassel, and R. H. Silverman. 1993. Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 72:753-765.